Pharma News 
Penwest Pharmaceuticals posts net income in Q4
Penwest Pharmaceuticals posts net income in Q4
Penwest Pharmaceuticals posts net income in Q4
Mar 05, 2010 (Datamonitor via COMTEX) -- Penwest Pharmaceuticals, a biopharmaceutical company, has reported a net income of $1.22 million or $0.04 per share, for the fourth quarter ended December 31, 2009, compared to a net loss of $2.23 million or $0.07 per share, for the fourth quarter ended December 31, 2008.
For the fourth quarter of 2009, total revenues were $6.99 million, compared to $5.12 million for the fourth quarter of 2008.
Net loss for the year ended December 31, 2009 was $1.5 million, or $0.05 per share, compared to a net loss of $26.73 million, or $0.89 per share, for the year ended December 31, 2008.
For the year 2009, total revenues were $23.81 million, compared to $8.53 million for the year 2008.
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Datamonitor shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon
| Isotechnika obtains funding from National Research Council for NICAM program< Prev | Next >Amarillo signs licensing and supply agreement with Intas Pharmaceuticals |
|---|
Main Menu
FREE Daily Update!
Sign up for the BHC DAILY UPDATE to get breaking behavioral healthcare news delivered daily to your inbox!
